Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,623
datasets available to search
ShareScore release 0.9.0
Dataset results
1,623 results for “hemodialysis”
A Study of LY2928057 in Hemodialysis Participants
ClinicalTrials.gov study NCT01991483. IPD Sharing: Not stated. Countries: 1. Publications: 1.
HeRO Graft Compared to Permanent Catheters for End Stage Renal Disease (ESRD) Patients Receiving Hemodialysis
ClinicalTrials.gov study NCT01343251. IPD Sharing: NO. Countries: 1. Publications: 14.
A Prospective Study of Airless Tubing in an Inpatient Acute Hemodialysis Unit in Hospitalized Patients
ClinicalTrials.gov study NCT02086682. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Self-monitoring of Weight & Blood Pressure (Via patientMpower Platform) in Hemodialysis
ClinicalTrials.gov study NCT03403491. IPD Sharing: NO. Countries: 1. Publications: 1.
Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis C
ClinicalTrials.gov study NCT03365635. IPD Sharing: NO. Countries: 1. Publications: 8.
Observational Study of Citrate Based Dialysis in Pediatric Patients Receiving Hemodialysis
ClinicalTrials.gov study NCT01590550. IPD Sharing: NO. Countries: 1. Publications: 4.
Efficacy and Safety Study of GSK1278863 in Japanese Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Taking Erythropoiesis Stimulating Agents
ClinicalTrials.gov study NCT02829320. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study of Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia
ClinicalTrials.gov study NCT00661505. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Peer Mentorship to Improve Outcomes in Patients on Maintenance Hemodialysis
ClinicalTrials.gov study NCT03595748. IPD Sharing: NO. Countries: 1. Publications: 1.
Monitoring in Dialysis -- a Prospective, Multi-center, Single-arm, Non-randomized, Observational Study in Patients Who Are Undergoing Hemodialysis.
ClinicalTrials.gov study NCT01779856. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis Patients
ClinicalTrials.gov study NCT01435174. IPD Sharing: Not stated. Countries: 1. Publications: 1.
CR845-CLIN3105: A Study to Evaluate the Safety and Effectiveness of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
ClinicalTrials.gov study NCT03998163. IPD Sharing: NO. Countries: 4. Publications: 5.
Study to Evaluate the Safety, Efficacy and Pharmacokinetics of GSK1278863 in Japanese Hemodialysis-Dependent Subjects With Anemia Associated With Chronic Kidney Disease
ClinicalTrials.gov study NCT02019719. IPD Sharing: YES. Countries: 1. Publications: 1.
Comparative Study of the Efficacy of SARNA Sensitive Lotion for Treatment of Uremic Itch in Adult Hemodialysis Patients
ClinicalTrials.gov study NCT00693654. IPD Sharing: NO. Countries: 1. Publications: 1.
Chlorhexidine Dressings for Hemodialysis Catheter Exit Site Care: Comparative Study
ClinicalTrials.gov study NCT05855616. IPD Sharing: NO. Countries: 1. Publications: 4.
Data from: Characterization of gut microbiota composition in hemodialysis patients with normal weight obesity
Open the record for dataset details and reuse information.
Safety of ChAdOx1 nCoV-19 vaccination in patients with end-stage renal disease on hemodialysis
Open the record for dataset details and reuse information.
Consolidated criteria for reporting qualitative studies (COREQ): 32-item checklist for "The experience of adherence among hemodialysis patients undergoing therapeutic regimen: a qualitative study"
<p>Reporting guidelines Consolidated criteria for reporting qualitative studies (COREQ): 32-item checklist for "The experience of adherence among hemodialysis patients undergoing therapeutic regimen: a qualitative study"</p>
Risk for excessive anticoagulation during hemodialysis is associated with type of vascular access and bedside coagulation testing: Results of a cross-sectional study
<p>Anonymized dataset of the cross-sectional study assessing (i) heparin dosing within a prevalent hemodialysis cohort, (ii) the anticoagulant effects of the heparinization strategy and (iii) identifying predictive factors of the heparin dosing regimen.</p>
Data from: Clinical Outcomes Associated with the use of the NexSite™ Hemodialysis Catheter with New Exit Barrier Technology: Results from a Prospective, Observational Multi-center Registry Study
Purpose: Decreasing the risk of catheter related bloodstream infections (CRBSIs) remains a key focus for improving outcomes and reducing cost of care for hemodialysis (HD) patients. Recent studies demonstrate CRBSI rates can be improved by managing bacterial colonization at the catheter exit site. Herein we present the results of a study documenting the clinical performance of the NexSite® HD catheter, a new tunneled central venous catheter which incorporates Exit Site Management (ESM) technology. Methods: We conducted an observational study using a prospective, multi-center registry of HD patients implanted with the NexSite® HD catheter. The primary endpoint for the study was CRBSI rate for a period up to 180-days following catheter placement. Secondary endpoints included device placement success rate, exit site healing, development of an exit site or tunnel infection, and early or late non-infectious catheter-related complications. All reasons for early non-elective catheter removal were recorded. Results: A total of 115 HD patients at 6 sites were included in the final analysis. Cumulative catheter use was 10,924 days with a mean duration of 95 days. Seven patients experienced CRBSIs during the study period resulting in a CRBSI rate of 0.64 per 1,000 catheter-days. Seventy-four patients (64.3%) had either elective catheter removal (n=56) or utilized the catheter for the entire 180-day observation period (n=18). Thirty-five patients (30%) underwent non-elective device removal either due to CRBSI (n=5), low flow (n=16), exit site issues (n=7), or for other causes (n=7). Six patients died during the observation period with 1 death due to CRBSI-associated complications and the remaining 5 deaths attributed to non-device related causes. Conclusion: Our findings demonstrate that the NexSite HD catheter equipped with ESM technology can achieve a CRBSI rate in compliance with the NKF KDOQI (National Kidney Foundation Kidney Disease Outcome Quality Initiatives) Clinical Performance Guidelines stated goal of less than 1.0/1,000 catheter-days when used in hemodialysis patients using current standard of care nursing protocols.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.